Drug discovery and compound screening

Step-by-Step Breakdown

Detailed explanation of each automated stage in the workflow.

1. 1

   Trigger

   Target validation completed

   A new biological target has been validated for therapeutic intervention and entered into the drug discovery pipeline. The target information is logged in the research database with associated disease indication.

   LIMSElectronic Lab Notebooks
2. 2

   Action

   Generate compound library query

   Bioinformatics software analyzes target structure and generates optimized parameters for compound library screening. Virtual screening filters are applied to identify potential binding candidates.

   Bioinformatics software suitesLIMS
3. 3

   Action

   Execute automated screening assays

   High-throughput screening protocols are automatically configured and executed against the compound library. Assay data is captured and integrated into the laboratory management system.

   LIMSMass spectrometry data systemsElectronic Lab Notebooks
4. 4

   Decision

   Evaluate hit compound criteria

   Automated analysis determines if screening results meet predefined hit criteria for potency, selectivity, and drug-like properties. Compounds are classified as hits, near-hits, or failures.

   Bioinformatics software suitesLIMS
5. 5

   Action

   Validate promising hits

   Hit compounds undergo secondary assays for confirmation including dose-response curves and selectivity panels. Validated hits are prioritized for lead optimization studies.

   LIMSMass spectrometry data systemsElectronic Lab Notebooks
6. 6

   Action

   Prepare regulatory documentation

   Comprehensive screening data packages are compiled and formatted for regulatory submissions and intellectual property filings. Documentation includes assay protocols, results, and safety assessments.

   Regulatory submission platformsElectronic Lab Notebooks
7. 7

   Output

   Generate discovery report

   Final drug discovery report is produced containing validated hits, screening statistics, next steps recommendations, and regulatory-ready documentation. Report is distributed to stakeholders and archived.

   Electronic Lab NotebooksRegulatory submission platforms

Related Biotech Articles